# Synthesis and Pesticidal Activities of 5-(2-Cyclopropylaminopyrimidin-4-yl)-4-(thiophenyl)thiazole Derivatives

Authors: Won-Sik Choi; Seok-Woo Nam; Il-Doo Kim; Seung-Han Kim; Kun-Ho Park; In-Kyung Bae; Eun-Sil Park; Hwang-Ju Jeon; Sung-Eun Lee
Journal: Journal of Chemistry
 (2015)

---

## Abstract

Pesticidal activities of 4-[5-(2-cyclopropylaminopyrimidin-4-yl)-4-(4-chloro-2-fluoro-phenyl)thiazol-2-yl]-1-methylpiperidine, designated as Comp I, have been determined against a mosquito larva,Culex pipiens pallens, and a phytopathogenic fungus, Phytophthora capsici. Comp I was used as the leading compound in this study. The compounds were synthesized by reacting them with two functional groups, 3-thiophenyl and 2-thiophenyl groups, instead of 4-chloro-2-fluorophenyl group in Comp I. Other functional groups such as 2-aminothiazole, 2-(1-methylpiperazin-4-yl)thiazole, and 2-(piperazin-4-yl)thiazole were also introduced instead of 2-methylpiperidin-4-yl-thiazole of Comp I. Compounds designated as XIII-6~XV-7 were newly synthesized and their structures were confirmed by 1H- and 13C-NMR spectroscopy. Mosquito larvicidal activities of all the synthesized compounds against C. pipiens pallens were examined and Comp I among them showed the strongest larvicidal activity as 0.513 mM of LC50 value. The fungicidal activities of all the synthesized compounds against P. capsici were examined using the whole plant method. Among the XIII-6~XV-7 chemicals, 5-(2-cyclopropylaminopyrimidin-4-yl)-4-(thiophen-2-yl)thiazol-2-amine (VIII-6) showed the most potent antifungal activity in vivo. While the EC50 value of the commercial fungicide dimethomorph was 4.26 μM, EC50 of VIII-6 was 0.94 μM. Therefore, thiazole derivatives can be considered as viable candidates for the control of mosquito larvae and plant diseases.


---

## Body

## 1. Introduction

The mosquitos have contributed to emerging infectious diseases including malaria, filariasis, dengue, yellow fever, and Japanese encephalitis, leading to death. Among them,vivax malaria reemerges in South Korea and the control strategy for the vectors needs to be changed [1]. The control of mosquitoes using conventional insecticides is one of efficient methods to decrease malaria incidence in South Korea. However, there are many reports that show high insecticide resistance found in the mosquitos in South Korea [2]. Therefore, there is increasing need to develop new insecticides for the control of mosquitoes in public.Similarly, new antifungal compounds are needed to control phytopathogenic diseases to protect crops from the fungal attack. Among the phytopathogenic diseases,Phytophthora capsici is a soil-borne fungal pathogen that significantly hampers agricultural production of certain species of peppers [3]. Because of its highly destructive effect on infected plants, strategies to detectP. capsici and prevent infection by this pathogen have been extensively investigated. This infection can be readily found in pepper and tomato plants in South Korea [4]. To reduce the failure of fungal disease management by the currently used fungicides, new compounds with high efficacy and selectivity against target species are desirable [5]. Several studies on the synthesis of thiazole derivatives have already been published [6], reflecting the growing interest in the chemical and biological significance of this class of compounds [7]. 4-[5-(2-Cyclopropylaminopyrimidin-4-yl)-4-(4-fluorophenyl)-thiazol-2-yl]-1-methylpiperidine and 4-[5-(2-cyclopropylaminopyrimidin-4-yl)-4-(4-chloro-2-fluoro-phenyl)thiazol-2-yl]-1-methylpiperidine (Comp I) showed potential antifungal activityin vivo [8, 9].The objective of the present study was to develop a new environmentally sound pesticide to control mosquito larvae and the fungusP. blight by optimizing novel scaffolds for commercial use. Therefore, based on the structural features of thiazole, compounds that substituted phenyl group of Comp I with 3-thiophenyl or 2-thiophenyl group instead of 4-chloro-2-fluorophenyl group were designed and synthesized. The newly synthesized compounds’ pesticidal effects were determined on the mosquito larvae and the phytopathogenic fungus.


## 2. Materials and Methods

### 2.1. Mosquitoes and Pathogens

The stock culture ofCulex pipiens pallens was a laboratory strain (KS-CP, Korea National Institute of Health, Osong, Korea) which was susceptible to insecticides and maintained without exposure to further insecticides.P. capsici was kindly supplied by the National Institute of Agricultural Science and Technology (NAAS, Suwon, Korea). This species was subcultured on potato dextrose agar (PDA) (3.9 g) in water (100 mL) at 15 atm and 121°C for 15 min and then uniformly sprayed on a Petri dish.P. capsici was inoculated onto the medium at intervals of 5 mm and was then used to test for antifungal activity for 4~7 days at 20~25°C and 70% humidity in a dark room.


### 2.2. Materials

Piperazine, triethylamine, trifluoroacetic acid, isopentyl nitrite, 1-boc-4-piperidone, ethyl 4-carbamothioyl-piperidine-1-carboxylate, 2-mercapto-4-methylpyrimidine hydrochloride, iodomethane,O-dimethylhydroxyl-amine hydrochloride, thiophene-2-carbonyl chloride, thiophene-3-carbonyl chloride, lithium diisopropylamide (2.0 M), bromine, thiourea, sulfuryl chloride, isonipecotamide, Lawesson’s reagent, 3-chloroperoxybenzoic acid, 3-aminobenzyl alcohol, cyclopropylamine, trimethylsilyliodide, formaldehyde solution, and sodium borohydride were obtained from Aldrich Chemical (St. Louis, MO). PDA was supplied from Difco (Sparks, MD). Dimethomorph was supplied from Dongbu Hannong Co. (Daejeon, Korea). 1H- and 13C-NMR spectroscopy was carried out on a Bruker 400 NMR spectrometer (Bruker, Ettlingen, Germany). The IR spectra were recorded on a Jasco FT (Fourier Transform)/IR-4100 Fourier transform spectrometer (JASCO, Tokyo, Japan).


### 2.3.In Vivo Mosquito Larvicidal Activity

A direct-contact mortality bioassay was done on acetone serial dilution of the newly synthesized compounds to third instar larvae ofC. pipiens pallens. At least 20 mosquito larvae were separately deposited into a 250 mL beaker containing each test compound solution with five different concentrations. Chlorpyrifos was served as a positive control and prepared in acetone. All treatments were replicated three times using 20 larvae per replicate. Probit analysis was employed to calculate larvicidal activity of the tested compounds.


### 2.4.In Vivo Fungicidal Activity

Antifungal activities of the tested compounds were evaluated using the whole plant method in a greenhouse, as previously described [6, 8]. Briefly, a serial dilution of test compounds was prepared as 40, 35, 25, 20, and 12.5 mg/L. Fifty mL of each test sample solution was sprayed into two pots and the treated red pepper plants were left in a greenhouse for 1 day before inoculation with the pathogen. The prepared red pepper plants were then inoculated by spraying conidia (1 × 104 spores/mL) ofP. capsici on the leaves. Dimethomorph was used as a positive control. All tests were triplicated and the effect of the test compound was evaluated with a control value (CV) calculated using the formula CV(%)=[(A-B)/A]×100. A and B represent the disease area on the untreated and treated plants, respectively.


### 2.5. Statistical Analysis

Analysis of variance was performed with the procedure formulated by SAS version 9.1 (SAS Institute, Cary, NC). IfP>F was less than 0.01, the means were separated with the least significant difference (LSD) test at the P=0.05 level.


### 2.6. Synthesis

Synthesis of compounds designated as VIII-6 and XIII-6~XV-7 is shown in Figure2. Compounds I, VII, and XII were synthesized by the method previously reported [10]. Compound II was synthesized by the method previously reported [11], and IX and XI were synthesized by the method of [8]. Compound X by the method of [12] and XIII~XV compounds [9] were synthesized.


### 2.7. 5-(2-Cyclopropylaminopyrimidin-4-yl)-4-(thiophenyl)thiazol-2-amine Derivatives (VIII-6~VIII-7)

A mixture of 5-(2-(methylsulfinyl)pyrimidin-4-yl)-4-(thiophen-2-yl)thiazol-2-amine (VII-6) (0.90 g, 3.14 mmole) and 5-(2-(methylsulfinyl)pyrimidin-4-yl)-4-(thiophen-3-yl)thiazol-2-amine (VII-7) (0.90 g, 3.14 mmole) in cyclopropylamine (1.63 g, 28.70 mmole) was stirred for 2 h at 100°C. The mixture was poured into 5% HCl solution (5 mL) and extracted with ethyl acetate (5 mL). The combined organic phase was dried (magnesium sulfate) and evaporated. The residue was recrystallized from ethyl acetate and hexane to give VIII-6 (0.80 g) and VIII-7 (0.82 g) as yellow solids.VIII-6. Yield 81.2%; 1H-NMR (400 MHz, CDCl3) δ 0.57 (d, 2H, -CCH2CH2-), 0.77–0.86 (d, 2H, -CCH2CH2-), 6.71–6.72 (d, 1H, -CH=CH-N), 7.05–7.08 (t, 1H, -CH=CH-S), 7.38–7.39 (d, 1H, -CH=CH-N), 7.41–7.43 (d, 1H, =CH-S-), 8.11–8.13 (d, 1H, =CH-CH=CH-S). 13C-NMR (100 MHz, CDCl3) δ 7.9 (CH-CH2-CH2), 27.0 (NH-CH), 107.8 (C=CH-CH), 122.2 (C=C-S, C), 127.6 (C=CH-CH), 129.5 (CH=CH-CH), 127.6 (CH=CH-S), 137.9 (C, S-C=CH) 140.5 (C, N-C=C), 151.2 (N-CH=CH), 159.9 (CH, CH-C=N), 161.1 (NH, N-C=N), 169.2 (S, NH2-C=N).VIII-7. Yield 83.2%; 1H-NMR (400 MHz, CDCl3) δ 0.56 (d, 2H, -CCH2CH2-), 0.76–0.88 (d, 2H, -CCH2CH2-), 6.25–6.27 (d, 1H, -CH=CH-N), 7.41–7.84 (t, 1H, -CH=CH-S), 7.95–8.08 (d, 1H, -CH=CH-S), 8.17–8.19 (d, 1H, -CH=CH-N), 8.31–8.52 (d, 1H, -C=CH-S). 13C-NMR (100 MHz, CDCl3) δ 7.6 (CH-CH2-CH2), 26.0 (NH-CH), 108.7 (C=CH-CH), 121.1 (S-CH=C), 121.8 (C=C-S, C), 127.8 (CH=CH-S), 128.5 (CH=CH-C), 142.3 (CH, CH-C=C), 142.2 (C, N-C=C), 158.0 (N-CH=CH), 161.9 (CH, CH-C=N), 162.4 (NH, N-C=N), 166.9 (S, NH2-C=N).


### 2.8. Ethyl 5-(2-Cyclopropylaminopyrimidin-4-yl)-4-(thiophenyl)thiazol-2-yl-piperidine-1-carboxylate Derivatives (XIII-6~XIII-7)

Application of the VIII method described above afforded XIII-6 (0.43 g) and XIII-7 (0.41 g) as yellow solids.XIII-6. Yield 68.4%; 1H-NMR (400 MHz, CDCl3) δ 0.81–0.84 (d, 4H, -CH(CH2)2), 1.34–1.41 (t, 3H, -CH2CH3), 1.83–2.18 (q, 4H, -CHCH2CH2-), 2.35–3.28 (quin, 1H, -CHCH2CH2-), 3.31–3.65 (quin, 4H -CHCH2CH2-), 3.91–4.58 (m, 1H, -CH(CH2)2), 4.68–4.80 (q, 2H, -CH2CH3), 6.65–6.67 (d, 1H, -CH=CH-N), 7.41–7.56 (t, 1H, -CH=CH-S), 8.21–8.23 (d, 1H, -CH=CH-N), 8.45–8.47 (d, 1H, =CH-S-), 8.54–8.56 (d, 1H, =CH-CH=CH-S). 13C-NMR (100 MHz, CDCl3) δ 7.4 (CH-CH2-CH2), 13.8 (CH2-CH3), 27.1 (NH-CH-CH2, CH2), 29.1 (CH-CH2-CH2), 37.2 (C-CH-CH2, CH2), 46.1 (CH2-CH2-N), 62.0 (O-CH2-CH3), 107.8 (CH-CH=C), 127.6 (CH-CH=C), 128.0 (CH-CH=CH), 128.6 (CH=C-S), 132.9 (C, S-C=C), 139.9 (C, S-C=CH), 146.3 (C, N-C=C), 155.4 (N, O-C=O), 157.2 (N=CH-CH), 157.7 (N, C-C=CH), 162.0 (NH, N-C=N), 175.6 (S, CH-C=N).XIII-7. Yield 67.3%; 1H-NMR (400 MHz, CDCl3) δ 0.85–0.87 (d, 4H, -CH(CH2)2), 1.35–1.48 (t, 3H, -CH2CH3), 1.88–2.14 (q, 4H, -CHCH2CH2-), 2.37–3.21 (quin, 1H, -CHCH2CH2-), 3.43–3.61 (quin, 4H -CHCH2CH2-), 3.96–4.51 (m, 1H, -CH(CH2)2), 4.61–4.86 (q, 2H, -CH2CH3), 6.63–6.65 (d, 1H, -CH=CH-N), 7.41–7.56 (t, 1H, -CH=CH-S), 7.81–7.85 (d, 1H, -CH=CH-S-), 8.25–8.27 (d, 1H, -CH=CH-N), 8.41–8.43 (d, 1H, -C=CH-S). 13C-NMR (100 MHz, CDCl3) δ 7.4 (CH-CH2-CH2), 14.1 (CH2-CH3), 27.5 (NH-CH-CH2, CH2), 29.1 (CH-CH2-CH2), 37.1 (C-CH-CH2, CH2), 46.5 (CH2-CH2-N), 62.5 (O-CH2-CH3), 107.5 (CH-CH=C), 121.6 (S-CH=C), 128.2 (CH=CH-S), 128.3 (CH=CH-C), 132.5 (C, S-C=C), 142.5 (C, C-C=CH), 146.6 (C, N-C=C), 155.1 (N, O-C=O), 157.9 (N=CH-CH), 157.7 (N, C-C=CH), 162.0 (NH, N-C=N), 175.8 (S, CH-C=N).


### 2.9. 5-(2-Cyclopropylaminopyrimidin-4-yl)-4-(thiophenyl)thiazol-2-yl-piperidine Derivatives (XIV-6~XIV-7)

Trimethylsilyliodide (1.27 g, 6.36 mM) was added to a solution of XIII-6 (0.85 g, 1.88 mmole) and XIII-7 (0.85 g, 1.88 mmole), in chloroform 10 mL. After the addition was completed, the resulting mixture was stirred at 60°C for 4 h. Subsequently, 10 mL of 6 M HCl in isopropanol and 10 mL of 2 M NaOH solution were added to the mixture. The organic phase was then separated, dried (magnesium sulfate), and evaporated to yield a residue. The residue was recrystallized from methylene chloride and ether to give XIV-6 (0.50 g) and XIV-7 (0.44 g) as yellow solids.XIV-6. Yield 52.5%; 1H-NMR (400 MHz, CDCl3) δ 0.85–0.87 (d, 4H, -CH(CH2)2), 1.81–2.12 (q, 4H, -CHCH2CH2-), 2.33–3.24 (quin, 1H, -CHCH2CH2-), 3.36–3.63 (quin, 4H, -CHCH2CH2-), 3.95–4.54 (m, 1H, -CH(CH2)2), 6.62–6.65 (d, 1H, -CH=CH-N), 7.46–7.57 (t, 1H, -CH=CH-S), 8.25–8.27 (d, 1H, -CH=CH-N), 8.43–8.45 (d, 1H, =CH-S-), 8.51–8.53 (d, 1H, =CH-CH=CH-S). 13C-NMR (100 MHz, CDCl3) δ 7.4 (CH-CH2-CH2), 28.0 (NH-CH-CH2, CH2), 32.4 (CH-CH2-CH2), 39.5 (C-CH-CH2, CH2), 41.8 (CH2-CH2-NH), 107.8 (CH-CH=C), 127.6 (CH-CH=C), 128.0 (CH-CH=CH), 129.6 (CH=C-S), 133.2 (C, S-C=C), 139.8 (C, S-C=CH), 146.3 (C, N-C=C), 157.2 (N=CH-CH), 158.8 (N, C-C=CH), 162.0 (NH, N-C=N), 175.5 (S, CH-C=N).XIV-7. Yield 52.2%; 1H-NMR (400 MHz, CDCl3) δ 0.88–0.90 (d, 4H, -CH(CH2)2), 1.84–2.15 (q, 4H, -CHCH2CH2-), 2.32–3.24 (quin, 1H, -CHCH2CH2-), 3.41–3.63 (quin, 4H, -CHCH2CH2-), 3.95–4.55 (m, 1H, -CH(CH2)2), 6.62–6.64 (d, 1H, -CH=CH-N), 7.43–7.52 (t, 1H, -CH=CH-S), 7.86–7.88 (d, 1H, -CH=CH-S-), 8.22–8.24 (d, 1H, -CH=CH-N), 8.45–8.47 (d, 1H, -C=CH-S). 13C-NMR (10 MHz, CDCl3) δ 7.4 (CH-CH2-CH2), 28.0 (NH-CH-CH2, CH2), 32.3 (CH-CH2-CH2), 39.6 (C-CH-CH2, CH2), 41.0 (CH2-CH2-NH), 107.9 (CH-CH=C), 121.7 (S-CH=C), 129.0 (CH=CH-C), 129.5 (CH=CH-S), 132.9 (C, S-C=C), 142.3 (CH-C=CH), 147.3 (C, N-C=C), 157.7 (N, C-C=CH), 158.2 (N=CH-CH), 161.9 (NH, N-C=N), 176.0 (S, CH-C=N).


### 2.10. 5-(2-Cyclopropylaminopyrimidin-4-yl)-4-(thiophenyl)thiazol-2-yl-1-methylpiperidine Derivatives(XV-6~XV-7)

Formaldehyde (0.13 g, 5.02 mM) and sodium borohydride (0.16 g, 5.02 mM) were added to a solution of XIV-6 (0.82 g, 2.17 mmole) and XIV-7 (0.82 g, 2.17 mmole), in methanol (10 mL). After accumulation, the resulting mixture was stirred at room temperature for 30 min, followed by the addition of 10 mL water and 10 mL ethyl acetate. The organic phase was then separated, dried (magnesium sulfate), and evaporated to yield residue. The residue was recrystallized from methylene chloride and ether to give XV-6 (0.31 g) and XV-7 (0.32 g) as yellow solids.XV-6. Yield 36.5%; 1H-NMR (400 MHz, CDCl3) δ 0.85–0.87 (d, 4H, -CH(CH2)2), 1.81–2.12 (q, 4H, -CHCH2CH2-), 2.20 (s, 3H, -NCH3), 2.33–3.24 (quin, 1H, -CHCH2CH2-), 3.36–3.63 (quin, 4H, -CHCH2CH2-), 3.95–4.54 (m, 1H, -CH(CH2)2), 6.62–6.65 (d, 1H, -CH=CH-N), 7.46–7.57 (t, 1H, -CH=CH-S), 8.25–8.27 (d, 1H, -CH=CH-N), 8.43–8.45 (d, 1H, =CH-S-), 8.51–8.53 (d, 1H, =CH-CH=CH-S). 13C-NMR (100 MHz, CDCl3) δ 7.5 (CH-CH2-CH2), 28.1 (NH-CH-CH2, CH2), 29.9 (CH-CH2-CH2), 38.5 (C-CH-CH2, CH2), 46.9 (N-CH3), 58.8 (CH2-CH2-N), 105.9 (CH-CH=C), 128.4 (CH-CH=C), 128.7 (CH-CH=CH), 129.6 (CH=C-S), 133.2 (C, S-C=C), 139.6 (C, S-C=CH), 146.3 (C, N-C=C), 157.1 (N=CH-CH), 158.7 (N, C-C=CH), 161.8 (NH, N-C=N), 176.6 (S, CH-C=N).XV-7. Yield 37.2%; 1H-NMR (400 MHz, CDCl3) δ 0.88–0.90 (d, 4H, -CH(CH2)2), 1.84–2.15 (q, 4H, -CHCH2CH2-), 2.26 (s, 3H, -NCH3), 2.32–3.24 (quin, 1H, -CHCH2CH2-), 3.41–3.63 (quin, 4H, -CHCH2CH2-), 3.95–4.55 (m, 1H, -CH(CH2)2), 6.62–6.64 (d, 1H, -CH=CH-N), 7.43–7.52 (t, 1H, -CH=CH-S), 7.86–7.88 (d, 1H, -CH=CH-S-), 8.22–8.24 (d, 1H, -CH=CH-N), 8.45–8.47 (d, 1H, -C=CH-S). 13C-NMR (100 MHz, CDCl3) δ 7.5 (CH-CH2-CH2), 28.1 (NH-CH-CH2, CH2), 29.8 (CH-CH2-CH2), 38.5 (C-CH-CH2, CH2), 46.9 (N-CH3), 58.9 (CH2-CH2-NH), 107.7 (CH-CH=C), 121.5 (S-CH=C), 128.9 (CH=CH-S), 129.8 (CH=CH-C), 132.9 (C, S-C=C), 142.3 (CH-C=CH), 146.3 (C, N-C=C), 157.7 (N, C-C=CH), 158.7 (N=CH-CH), 161.8 (NH, N-C=N), 176.6 (S, CH-C=N).


## 2.1. Mosquitoes and Pathogens

The stock culture ofCulex pipiens pallens was a laboratory strain (KS-CP, Korea National Institute of Health, Osong, Korea) which was susceptible to insecticides and maintained without exposure to further insecticides.P. capsici was kindly supplied by the National Institute of Agricultural Science and Technology (NAAS, Suwon, Korea). This species was subcultured on potato dextrose agar (PDA) (3.9 g) in water (100 mL) at 15 atm and 121°C for 15 min and then uniformly sprayed on a Petri dish.P. capsici was inoculated onto the medium at intervals of 5 mm and was then used to test for antifungal activity for 4~7 days at 20~25°C and 70% humidity in a dark room.


## 2.2. Materials

Piperazine, triethylamine, trifluoroacetic acid, isopentyl nitrite, 1-boc-4-piperidone, ethyl 4-carbamothioyl-piperidine-1-carboxylate, 2-mercapto-4-methylpyrimidine hydrochloride, iodomethane,O-dimethylhydroxyl-amine hydrochloride, thiophene-2-carbonyl chloride, thiophene-3-carbonyl chloride, lithium diisopropylamide (2.0 M), bromine, thiourea, sulfuryl chloride, isonipecotamide, Lawesson’s reagent, 3-chloroperoxybenzoic acid, 3-aminobenzyl alcohol, cyclopropylamine, trimethylsilyliodide, formaldehyde solution, and sodium borohydride were obtained from Aldrich Chemical (St. Louis, MO). PDA was supplied from Difco (Sparks, MD). Dimethomorph was supplied from Dongbu Hannong Co. (Daejeon, Korea). 1H- and 13C-NMR spectroscopy was carried out on a Bruker 400 NMR spectrometer (Bruker, Ettlingen, Germany). The IR spectra were recorded on a Jasco FT (Fourier Transform)/IR-4100 Fourier transform spectrometer (JASCO, Tokyo, Japan).


## 2.3.In Vivo Mosquito Larvicidal Activity

A direct-contact mortality bioassay was done on acetone serial dilution of the newly synthesized compounds to third instar larvae ofC. pipiens pallens. At least 20 mosquito larvae were separately deposited into a 250 mL beaker containing each test compound solution with five different concentrations. Chlorpyrifos was served as a positive control and prepared in acetone. All treatments were replicated three times using 20 larvae per replicate. Probit analysis was employed to calculate larvicidal activity of the tested compounds.


## 2.4.In Vivo Fungicidal Activity

Antifungal activities of the tested compounds were evaluated using the whole plant method in a greenhouse, as previously described [6, 8]. Briefly, a serial dilution of test compounds was prepared as 40, 35, 25, 20, and 12.5 mg/L. Fifty mL of each test sample solution was sprayed into two pots and the treated red pepper plants were left in a greenhouse for 1 day before inoculation with the pathogen. The prepared red pepper plants were then inoculated by spraying conidia (1 × 104 spores/mL) ofP. capsici on the leaves. Dimethomorph was used as a positive control. All tests were triplicated and the effect of the test compound was evaluated with a control value (CV) calculated using the formula CV(%)=[(A-B)/A]×100. A and B represent the disease area on the untreated and treated plants, respectively.


## 2.5. Statistical Analysis

Analysis of variance was performed with the procedure formulated by SAS version 9.1 (SAS Institute, Cary, NC). IfP>F was less than 0.01, the means were separated with the least significant difference (LSD) test at the P=0.05 level.


## 2.6. Synthesis

Synthesis of compounds designated as VIII-6 and XIII-6~XV-7 is shown in Figure2. Compounds I, VII, and XII were synthesized by the method previously reported [10]. Compound II was synthesized by the method previously reported [11], and IX and XI were synthesized by the method of [8]. Compound X by the method of [12] and XIII~XV compounds [9] were synthesized.


## 2.7. 5-(2-Cyclopropylaminopyrimidin-4-yl)-4-(thiophenyl)thiazol-2-amine Derivatives (VIII-6~VIII-7)

A mixture of 5-(2-(methylsulfinyl)pyrimidin-4-yl)-4-(thiophen-2-yl)thiazol-2-amine (VII-6) (0.90 g, 3.14 mmole) and 5-(2-(methylsulfinyl)pyrimidin-4-yl)-4-(thiophen-3-yl)thiazol-2-amine (VII-7) (0.90 g, 3.14 mmole) in cyclopropylamine (1.63 g, 28.70 mmole) was stirred for 2 h at 100°C. The mixture was poured into 5% HCl solution (5 mL) and extracted with ethyl acetate (5 mL). The combined organic phase was dried (magnesium sulfate) and evaporated. The residue was recrystallized from ethyl acetate and hexane to give VIII-6 (0.80 g) and VIII-7 (0.82 g) as yellow solids.VIII-6. Yield 81.2%; 1H-NMR (400 MHz, CDCl3) δ 0.57 (d, 2H, -CCH2CH2-), 0.77–0.86 (d, 2H, -CCH2CH2-), 6.71–6.72 (d, 1H, -CH=CH-N), 7.05–7.08 (t, 1H, -CH=CH-S), 7.38–7.39 (d, 1H, -CH=CH-N), 7.41–7.43 (d, 1H, =CH-S-), 8.11–8.13 (d, 1H, =CH-CH=CH-S). 13C-NMR (100 MHz, CDCl3) δ 7.9 (CH-CH2-CH2), 27.0 (NH-CH), 107.8 (C=CH-CH), 122.2 (C=C-S, C), 127.6 (C=CH-CH), 129.5 (CH=CH-CH), 127.6 (CH=CH-S), 137.9 (C, S-C=CH) 140.5 (C, N-C=C), 151.2 (N-CH=CH), 159.9 (CH, CH-C=N), 161.1 (NH, N-C=N), 169.2 (S, NH2-C=N).VIII-7. Yield 83.2%; 1H-NMR (400 MHz, CDCl3) δ 0.56 (d, 2H, -CCH2CH2-), 0.76–0.88 (d, 2H, -CCH2CH2-), 6.25–6.27 (d, 1H, -CH=CH-N), 7.41–7.84 (t, 1H, -CH=CH-S), 7.95–8.08 (d, 1H, -CH=CH-S), 8.17–8.19 (d, 1H, -CH=CH-N), 8.31–8.52 (d, 1H, -C=CH-S). 13C-NMR (100 MHz, CDCl3) δ 7.6 (CH-CH2-CH2), 26.0 (NH-CH), 108.7 (C=CH-CH), 121.1 (S-CH=C), 121.8 (C=C-S, C), 127.8 (CH=CH-S), 128.5 (CH=CH-C), 142.3 (CH, CH-C=C), 142.2 (C, N-C=C), 158.0 (N-CH=CH), 161.9 (CH, CH-C=N), 162.4 (NH, N-C=N), 166.9 (S, NH2-C=N).


## 2.8. Ethyl 5-(2-Cyclopropylaminopyrimidin-4-yl)-4-(thiophenyl)thiazol-2-yl-piperidine-1-carboxylate Derivatives (XIII-6~XIII-7)

Application of the VIII method described above afforded XIII-6 (0.43 g) and XIII-7 (0.41 g) as yellow solids.XIII-6. Yield 68.4%; 1H-NMR (400 MHz, CDCl3) δ 0.81–0.84 (d, 4H, -CH(CH2)2), 1.34–1.41 (t, 3H, -CH2CH3), 1.83–2.18 (q, 4H, -CHCH2CH2-), 2.35–3.28 (quin, 1H, -CHCH2CH2-), 3.31–3.65 (quin, 4H -CHCH2CH2-), 3.91–4.58 (m, 1H, -CH(CH2)2), 4.68–4.80 (q, 2H, -CH2CH3), 6.65–6.67 (d, 1H, -CH=CH-N), 7.41–7.56 (t, 1H, -CH=CH-S), 8.21–8.23 (d, 1H, -CH=CH-N), 8.45–8.47 (d, 1H, =CH-S-), 8.54–8.56 (d, 1H, =CH-CH=CH-S). 13C-NMR (100 MHz, CDCl3) δ 7.4 (CH-CH2-CH2), 13.8 (CH2-CH3), 27.1 (NH-CH-CH2, CH2), 29.1 (CH-CH2-CH2), 37.2 (C-CH-CH2, CH2), 46.1 (CH2-CH2-N), 62.0 (O-CH2-CH3), 107.8 (CH-CH=C), 127.6 (CH-CH=C), 128.0 (CH-CH=CH), 128.6 (CH=C-S), 132.9 (C, S-C=C), 139.9 (C, S-C=CH), 146.3 (C, N-C=C), 155.4 (N, O-C=O), 157.2 (N=CH-CH), 157.7 (N, C-C=CH), 162.0 (NH, N-C=N), 175.6 (S, CH-C=N).XIII-7. Yield 67.3%; 1H-NMR (400 MHz, CDCl3) δ 0.85–0.87 (d, 4H, -CH(CH2)2), 1.35–1.48 (t, 3H, -CH2CH3), 1.88–2.14 (q, 4H, -CHCH2CH2-), 2.37–3.21 (quin, 1H, -CHCH2CH2-), 3.43–3.61 (quin, 4H -CHCH2CH2-), 3.96–4.51 (m, 1H, -CH(CH2)2), 4.61–4.86 (q, 2H, -CH2CH3), 6.63–6.65 (d, 1H, -CH=CH-N), 7.41–7.56 (t, 1H, -CH=CH-S), 7.81–7.85 (d, 1H, -CH=CH-S-), 8.25–8.27 (d, 1H, -CH=CH-N), 8.41–8.43 (d, 1H, -C=CH-S). 13C-NMR (100 MHz, CDCl3) δ 7.4 (CH-CH2-CH2), 14.1 (CH2-CH3), 27.5 (NH-CH-CH2, CH2), 29.1 (CH-CH2-CH2), 37.1 (C-CH-CH2, CH2), 46.5 (CH2-CH2-N), 62.5 (O-CH2-CH3), 107.5 (CH-CH=C), 121.6 (S-CH=C), 128.2 (CH=CH-S), 128.3 (CH=CH-C), 132.5 (C, S-C=C), 142.5 (C, C-C=CH), 146.6 (C, N-C=C), 155.1 (N, O-C=O), 157.9 (N=CH-CH), 157.7 (N, C-C=CH), 162.0 (NH, N-C=N), 175.8 (S, CH-C=N).


## 2.9. 5-(2-Cyclopropylaminopyrimidin-4-yl)-4-(thiophenyl)thiazol-2-yl-piperidine Derivatives (XIV-6~XIV-7)

Trimethylsilyliodide (1.27 g, 6.36 mM) was added to a solution of XIII-6 (0.85 g, 1.88 mmole) and XIII-7 (0.85 g, 1.88 mmole), in chloroform 10 mL. After the addition was completed, the resulting mixture was stirred at 60°C for 4 h. Subsequently, 10 mL of 6 M HCl in isopropanol and 10 mL of 2 M NaOH solution were added to the mixture. The organic phase was then separated, dried (magnesium sulfate), and evaporated to yield a residue. The residue was recrystallized from methylene chloride and ether to give XIV-6 (0.50 g) and XIV-7 (0.44 g) as yellow solids.XIV-6. Yield 52.5%; 1H-NMR (400 MHz, CDCl3) δ 0.85–0.87 (d, 4H, -CH(CH2)2), 1.81–2.12 (q, 4H, -CHCH2CH2-), 2.33–3.24 (quin, 1H, -CHCH2CH2-), 3.36–3.63 (quin, 4H, -CHCH2CH2-), 3.95–4.54 (m, 1H, -CH(CH2)2), 6.62–6.65 (d, 1H, -CH=CH-N), 7.46–7.57 (t, 1H, -CH=CH-S), 8.25–8.27 (d, 1H, -CH=CH-N), 8.43–8.45 (d, 1H, =CH-S-), 8.51–8.53 (d, 1H, =CH-CH=CH-S). 13C-NMR (100 MHz, CDCl3) δ 7.4 (CH-CH2-CH2), 28.0 (NH-CH-CH2, CH2), 32.4 (CH-CH2-CH2), 39.5 (C-CH-CH2, CH2), 41.8 (CH2-CH2-NH), 107.8 (CH-CH=C), 127.6 (CH-CH=C), 128.0 (CH-CH=CH), 129.6 (CH=C-S), 133.2 (C, S-C=C), 139.8 (C, S-C=CH), 146.3 (C, N-C=C), 157.2 (N=CH-CH), 158.8 (N, C-C=CH), 162.0 (NH, N-C=N), 175.5 (S, CH-C=N).XIV-7. Yield 52.2%; 1H-NMR (400 MHz, CDCl3) δ 0.88–0.90 (d, 4H, -CH(CH2)2), 1.84–2.15 (q, 4H, -CHCH2CH2-), 2.32–3.24 (quin, 1H, -CHCH2CH2-), 3.41–3.63 (quin, 4H, -CHCH2CH2-), 3.95–4.55 (m, 1H, -CH(CH2)2), 6.62–6.64 (d, 1H, -CH=CH-N), 7.43–7.52 (t, 1H, -CH=CH-S), 7.86–7.88 (d, 1H, -CH=CH-S-), 8.22–8.24 (d, 1H, -CH=CH-N), 8.45–8.47 (d, 1H, -C=CH-S). 13C-NMR (10 MHz, CDCl3) δ 7.4 (CH-CH2-CH2), 28.0 (NH-CH-CH2, CH2), 32.3 (CH-CH2-CH2), 39.6 (C-CH-CH2, CH2), 41.0 (CH2-CH2-NH), 107.9 (CH-CH=C), 121.7 (S-CH=C), 129.0 (CH=CH-C), 129.5 (CH=CH-S), 132.9 (C, S-C=C), 142.3 (CH-C=CH), 147.3 (C, N-C=C), 157.7 (N, C-C=CH), 158.2 (N=CH-CH), 161.9 (NH, N-C=N), 176.0 (S, CH-C=N).


## 2.10. 5-(2-Cyclopropylaminopyrimidin-4-yl)-4-(thiophenyl)thiazol-2-yl-1-methylpiperidine Derivatives(XV-6~XV-7)

Formaldehyde (0.13 g, 5.02 mM) and sodium borohydride (0.16 g, 5.02 mM) were added to a solution of XIV-6 (0.82 g, 2.17 mmole) and XIV-7 (0.82 g, 2.17 mmole), in methanol (10 mL). After accumulation, the resulting mixture was stirred at room temperature for 30 min, followed by the addition of 10 mL water and 10 mL ethyl acetate. The organic phase was then separated, dried (magnesium sulfate), and evaporated to yield residue. The residue was recrystallized from methylene chloride and ether to give XV-6 (0.31 g) and XV-7 (0.32 g) as yellow solids.XV-6. Yield 36.5%; 1H-NMR (400 MHz, CDCl3) δ 0.85–0.87 (d, 4H, -CH(CH2)2), 1.81–2.12 (q, 4H, -CHCH2CH2-), 2.20 (s, 3H, -NCH3), 2.33–3.24 (quin, 1H, -CHCH2CH2-), 3.36–3.63 (quin, 4H, -CHCH2CH2-), 3.95–4.54 (m, 1H, -CH(CH2)2), 6.62–6.65 (d, 1H, -CH=CH-N), 7.46–7.57 (t, 1H, -CH=CH-S), 8.25–8.27 (d, 1H, -CH=CH-N), 8.43–8.45 (d, 1H, =CH-S-), 8.51–8.53 (d, 1H, =CH-CH=CH-S). 13C-NMR (100 MHz, CDCl3) δ 7.5 (CH-CH2-CH2), 28.1 (NH-CH-CH2, CH2), 29.9 (CH-CH2-CH2), 38.5 (C-CH-CH2, CH2), 46.9 (N-CH3), 58.8 (CH2-CH2-N), 105.9 (CH-CH=C), 128.4 (CH-CH=C), 128.7 (CH-CH=CH), 129.6 (CH=C-S), 133.2 (C, S-C=C), 139.6 (C, S-C=CH), 146.3 (C, N-C=C), 157.1 (N=CH-CH), 158.7 (N, C-C=CH), 161.8 (NH, N-C=N), 176.6 (S, CH-C=N).XV-7. Yield 37.2%; 1H-NMR (400 MHz, CDCl3) δ 0.88–0.90 (d, 4H, -CH(CH2)2), 1.84–2.15 (q, 4H, -CHCH2CH2-), 2.26 (s, 3H, -NCH3), 2.32–3.24 (quin, 1H, -CHCH2CH2-), 3.41–3.63 (quin, 4H, -CHCH2CH2-), 3.95–4.55 (m, 1H, -CH(CH2)2), 6.62–6.64 (d, 1H, -CH=CH-N), 7.43–7.52 (t, 1H, -CH=CH-S), 7.86–7.88 (d, 1H, -CH=CH-S-), 8.22–8.24 (d, 1H, -CH=CH-N), 8.45–8.47 (d, 1H, -C=CH-S). 13C-NMR (100 MHz, CDCl3) δ 7.5 (CH-CH2-CH2), 28.1 (NH-CH-CH2, CH2), 29.8 (CH-CH2-CH2), 38.5 (C-CH-CH2, CH2), 46.9 (N-CH3), 58.9 (CH2-CH2-NH), 107.7 (CH-CH=C), 121.5 (S-CH=C), 128.9 (CH=CH-S), 129.8 (CH=CH-C), 132.9 (C, S-C=C), 142.3 (CH-C=CH), 146.3 (C, N-C=C), 157.7 (N, C-C=CH), 158.7 (N=CH-CH), 161.8 (NH, N-C=N), 176.6 (S, CH-C=N).


## 3. Results

To obtain new synthesized compounds (VIII-6~VIII-7 and XIII-6~XV-7) from Comp I (Figure1), 4-chloro-2-fluorophenyl group of Comp I was replaced with thiophen-3-yl and thiophen-2-yl groups. In addition, 4-aminothiazole, piperazin-4-yl-carboxylate, 2-(1-methylpiperazin-4-yl)thiazole, and 2-(piperazin-4-yl)thiazole were introduced as the leads instead of the 2-methyl piperidin-4-yl-thiazole group of Comp I. The synthesized compounds with this scheme are shown in Figure 2. Structure of compounds (XIII-6~XV-7) were confirmed by 1H- and 13C-NMR spectroscopy.Figure 1
Structure of 4-[5-(2-cyclopropylaminopyrimidin-4-yl)-4-(4-chloro-2-fluoro-phenyl)thiazol-2-yl]-1-methylpiperidine (Comp I).Figure 2
Synthesis of 5-(2-cyclopropylaminopyrimidin-4-yl)-4-(thiophenyl)thiazole-2-yl-2-amine (VIII) and 4-[5-(2-cyclopropylaminopyrimidin-4-yl)-4-(thiophenyl)thiazol-2-yl]piperidine derivatives (VIX-6~XV-7).Larvicidal activities of the synthesized compounds were determined (Table1) and Comp I showed the strongest activity in the tested compounds as the LC50 value of 0.513 mM. However, other synthesized compounds did not show any larvicidal activity against theC. pipiens pallens.Table 1
EC50 and LC50 values of pesticidal activities of VIII-6, VIII-7, XIV-6, XV-6, and XV-7 against P. capsici and Cx.p.  pallens.
Compounds
EC50 (EC90) values (mM)a
LC50 (mM) (CL, confident limits)
VIII-6
0.94 ± 0.01 (4.21 ± 0.05)
—
VIII-7
3.19 ± 0.02 (9.78 ± 0.03)
—
XIV-6
3.49 ± 0.07 (12.17 ± 0.04)
—
XV-6
0.96 ± 0.03 (5.64 ± 0.01)
—
XV-7
4.30 ± 0.05 (15.31 ± 0.02)
—
Comp I
0.98 ± 0.21 (5.85 ± 0.05)
0.513 (0.290–0.704)
Dimethomorph
4.26 ± 0.02 (14.72 ± 0.05)
Chlorpyrifos
0.0035 (0.0024–0.0047)
a
P < 0.05.
Values are means ± SD of three replicated tests.Fungicidal activities of the synthesized compounds were determined againstP. capsici. Comp I exhibited a strong inhibitory action with EC50 value of 0.98 mM on the growth ofP. capsici, whereas that of the commercial fungicide dimethomorph was 4.26 mM (Table 1). VIII-6 and XV-6 had potent fungicidal activities among the tested compounds with EC50 values of 0.94 and 0.96 mM, respectively.


## 4. Discussion

The conventional insecticides have been used to control mosquito-borne diseases by decreasing number of mosquito adults as well as larvae. However, many studies have reported that the resistance in mosquitoes to insecticides is common and increasing over the world [2]. The occurrence of resistance in insect pests to conventional insecticides has evoked to study new compounds with novel mode of action. Recently, several reports have found some natural products having mosquito larvicidal activity and antifungal activity [13]. The authors reported eleven compounds isolated from the heartwood ofMansonia gagei showed their larvicidal activities againstAedes aegypti, as well as their antifungal activities againstCladosporium cucumerinum andCandida albicans [13]. It is interesting that one compound may possess biological activities to control both fungi and insects. Mansonone C was the most potent compound with antifungal and larvicidal properties in the plantM. gagei. On the other hand, new synthesized compounds can contribute to control of mosquito larvae as well as natural products [14]. They synthesized 20 isoxaole derivatives and found potent larvicidal activities towardsA. aegypti larvae [14].Our previous studies were focused on developing new antifungal compounds to selectively controlP. capsici [6, 8, 9]. Therefore, 4-[5-(2-cyclopropylaminopyrimidin-4-yl)-4-(4-chloro-2-fluoro-phenyl)thiazol-2-yl]-1-methylpiperidine (Comp I) is found to show potent antifungal activity towardsP. capsici [6, 8, 9]. With these schemes, Comp I appeared to be suitable for use as a leading compound for further synthesis to controlP. capsici as well as mosquito larvae. A series of new compounds that possessed the thiophenyl group (VIII-6~VIII-7, XIII-6~XV-7) were successfully synthesized in our laboratory and their pesticidal activities towardsP. capsici as well as mosquito larvae ofC. pipiens pallenswere determined. The synthesized compounds showed their potent fungicidal effects onP. capsici as shown in Table 1. However, only Comp I showed a strong larvicidal activity towards mosquito larvae ofC. pipiens pallens (Table 1).With regard to structure-activity relationship of the newly synthesized compound VIII-6, the functional group on the thiazole ring of compounds such as 2-thiophenyl group may play an important role in the fungicidal activity againstP. capsici. A dramatic fungicidal effect was found in the compounds that possessed the 2-thiophenyl group on the thiazole ring designated as VIII-6. On the other hand, amine of piperidine groups containing 2-amino group among the newly synthesized compounds also showed fungicidal activity onP. capsici, and VIII-6 containing 2-aminothiazole group increased fungicidal activities with EC50 and EC90 values of 0.94 and 4.21 mM, respectively. Therefore, these compounds showed a gradual increase in fungicidal activity in the following order: XV-7, XIV-6, VIII-7, I, XV-6, and VIII-6 (Table 1). These data may be extremely useful for developing new fungicides from compounds that include an aryl halide.Taken together, all results confirmed our original proposal: thiazole compounds mixed with aryl halide groups on the thiazole ring could increase the fungicidal activity. However, these thiazole compounds did not possess any useful larvicidal activity.



---

*Source: 241793-2015-01-20.xml*